Cardiac Resynchronization Therapy Devices

"Cardiac Resynchronization Therapy Devices" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Types of artificial pacemakers with implantable leads to be placed at multiple intracardial sites. They are used to treat various cardiac conduction disturbances which interfere with the timing of contraction of the ventricles. They may or may not include defibrillating electrodes (IMPLANTABLE DEFIBRILLATORS) as well.

Descriptor ID	D058409
MeSH Number(s)	E07.305.250.750.500
Concept/Terms	Cardiac Resynchronization Therapy Devices Cardiac Resynchronization Therapy Devices Biventricular Pacemakers, Artificial Biventricular Pacemakers, Artificial Artificial Biventricular Pacemaker Artificial Biventricular Pacemakers Biventricular Pacemaker, Artificial Pacemaker, Artificial Biventricular Pacemakers, Artificial Biventricular

Below are MeSH descriptors whose meaning is more general than "Cardiac Resynchronization Therapy Devices".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Equipment and Supplies [E07]
Electrical Equipment and Supplies [E07.305]
Electrodes [E07.305.250]
Pacemaker, Artificial [E07.305.250.750]
Cardiac Resynchronization Therapy Devices [E07.305.250.750.500]

Below are MeSH descriptors whose meaning is related to "Cardiac Resynchronization Therapy Devices".

Below are MeSH descriptors whose meaning is more specific than "Cardiac Resynchronization Therapy Devices".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Cardiac Resynchronization Therapy Devices" by people in this website by year, and whether "Cardiac Resynchronization Therapy Devices" was a major or minor topic of these publications.

Bar chart showing 16 publications over 10 distinct years, with a maximum of 4 publications in 2011

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2011	4	0	4
2012	1	0	1
2014	1	0	1
2015	1	1	2
2017	0	2	2
2018	0	1	1
2019	2	0	2
2020	0	1	1
2021	0	1	1
2022	0	1	1

Below are the most recent publications written about "Cardiac Resynchronization Therapy Devices" by people in Profiles.

Gowani ZS, Tomashitis B, Vo CN, Field ME, Gold MR. Role of Electrical Delay in Cardiac Resynchronization Therapy Response. Card Electrophysiol Clin. 2022 06; 14(2):233-241.

View in: PubMed
Varma N, Auricchio A, Connolly AT, Boehmer J, Bahu M, Costanzo MR, Leonelli F, Yoo D, Singh J, Nabutovsky Y, Gold M. The cost of non-response to cardiac resynchronization therapy: characterizing heart failure events following cardiac resynchronization therapy. Europace. 2021 10 09; 23(10):1586-1595.

View in: PubMed
Filippatos G, Lu X, Tsintzos SI, Gold MR, Mullens W, Birnie D, Hersi AS, Kusano K, Leclercq C, Fagan DH, Wilkoff BL. Economic implications of adding a novel algorithm to optimize cardiac resynchronization therapy: rationale and design of economic analysis for the AdaptResponse trial. J Med Econ. 2020 Dec; 23(12):1401-1408.

View in: PubMed
Niu H, Yu Y, Sturdivant JL, An Q, Gold MR. The effect of posture, exercise, and atrial pacing on atrioventricular conduction in systolic heart failure. J Cardiovasc Electrophysiol. 2019 12; 30(12):2892-2899.

View in: PubMed
Singh JP, Abraham WT, Auricchio A, Delnoy PP, Gold M, Reddy VY, Sanders P, Lindenfeld J, Rinaldi CA. Design and rationale for the Stimulation Of the Left Ventricular Endocardium for Cardiac Resynchronization Therapy in non-responders and previously untreatable patients (SOLVE-CRT) trial. Am Heart J. 2019 11; 217:13-22.

View in: PubMed
Dewan P, Jhund PS, Shen L, Petrie MC, Abraham WT, Atif Ali M, Chen CH, Desai AS, Dickstein K, Huang J, Kiatchoosakun S, Kim KS, Køber L, Lai WT, Liao Y, Mogensen UM, Oh BH, Packer M, Rouleau JL, Shi V, Sibulo AS, Solomon SD, Sritara P, Swedberg K, Tsutsui H, Zile MR, McMurray JJV. Heart failure with reduced ejection fraction: comparison of patient characteristics and clinical outcomes within Asia and between Asia, Europe and the Americas. Eur J Heart Fail. 2019 May; 21(5):577-587.

View in: PubMed
Senfield J, Daubert C, Abraham WT, Ghio S, St John Sutton M, Cerkvenik J, Linde C, Gold MR. The Impact of the PR Interval in Patients Receiving Cardiac Resynchronization Therapy: Results From the REVERSE Study. JACC Clin Electrophysiol. 2017 08; 3(8):818-826.

View in: PubMed
Gold MR, Padhiar A, Mealing S, Sidhu MK, Tsintzos SI, Abraham WT. Economic Value and Cost-Effectiveness of Cardiac Resynchronization Therapy Among Patients With Mild Heart Failure: Projections From the REVERSE Long-Term Follow-Up. JACC Heart Fail. 2017 03; 5(3):204-212.

View in: PubMed
Zile MR, Sharma V, Johnson JW, Warman EN, Baicu CF, Bennett TD. Prediction of All-Cause Mortality Based on the Direct Measurement of Intrathoracic Impedance. Circ Heart Fail. 2016 Jan; 9(1):e002543.

View in: PubMed
Sturdivant JL, Gold MR. Biventricular pacemaker/defibrillators versus biventricular pacemakers in patients with non-ischemic cardiomyopathy. Card Electrophysiol Clin. 2015 Sep; 7(3):455-9.

View in: PubMed

People

Explore

Similar Concepts

Top Journals